12 private and public sector manufacturing facilities identified for increase in vaccine production.
Sanction of Rs 3,000 crore credit for Serum Institute and Rs 1,500 crore to Bharat Biotech for ramp up.
Emergency approval to vaccines approved for emergency use by credible foreign regulators